Philip Morris
Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
Fields
- Author
- Jackson, R.T.
- Kawachi, I.
- Pearce, N.E.
- Kawachi, I.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- ABST, ABSTRACT
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R529
- Named Organization
- Medical Research Council of New Zealand
- Natl Heart Foundation of New Zealand
- Wellington School of Medicine
- Natl Heart Foundation of New Zealand
- Author (Organization)
- Univ of Auckland
- Wellington School of Medicine
- Mrc
- Mccnz
- New Zealand Medical Journal
- Wellington School of Medicine
- Named Person
- Beaglehole, R.
- Bonita, R.
- Hay, D.
- Jackson, R.T.
- Kawachi, I.
- Laugreen, M.
- Bonita, R.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- bic02a00
Document Images
NOTICE
This matzrial' may be
THE pr3tected by Copyright
law ;>'.itle 17 U:S. Codel.
NEW ZEALAND
MEDICAL JOURNAL
12 July 1989
Vol'ume 102
lu o 871,
Deaths from lung cancer and ischaernic heart disease due to
passive smoking in New Zealand
I Kawachi MB, ChB. MRC Training Fellow in Epidemiology; N E Pearce PhD, Lecturar in Epidemiology.
Department
of Community Hea/th. W.Ninqton School of Medicine. Wellington; R T Jackson MCCNZ. Research Fellow in
Epidemiolopy. Department of Community H.atth, University of Auckland School of Medicine, Auckland
Abstract
Pausive smoking is increasingly recogni.ead'u a public haalth
hazard. Among New Zealanders who have never smoked. the
ptevaleacs of exposure to spousal smoking has been eatimated'
to be 12.7% for men and 16.1 % for women- The prevalence
of exposure to passive smoking in tbe workplYce has been
estimated to be 33.6% and 23.4% for never smoking men and
women respectively. Tba pooled risk estimatas from
epidemiological studies of the health effects of passive
smoking were used to estimate the numbers of deaths from
lung cancer and isrtia.r+;r heart dieeax attsibutable to paaova
smoking in New Zealand in 1985. The pooled relktive risk
estimates for lung cancer mortality were 1.3 (95% confidetue
interval (CII: 1.1-1.51 in both men and women expoeed' to
passive smoldng at home, and 2.2 (CI 1.4-3.0)'ia both men and
women exposed to passive smoking at work. Using these
relative risk estimates, it was calculated that 30 lung cancer
deaths (rangt: 11-41) were attributable to invohintLry'smoicn~
in New Zealand in 1985.
From pooled relative risk eetimates of ixhaamic heart
disease death of 1.3 (CI 1'.1-1.61 and' 1'.2(CI 1.1-1.4) for e:po.un
to spousal smoking in men and women respectively, it was
estimated that a further 91 isch.emic heart disease deatha
(range:, 39-177) were due to passive smoking at home. Tba
number of iscbaemic heart disease deaths due to passive
smoking in the workplace was even higher, at 152 (rangr.
62-2241. aas' R+ing relative risks of 2.3 (Cl 1.4-3.41 and 1.9 (CI
I.4-2.5) for men and' women respectively.
The total number of deaths due to passive smoking from
lung cancer and t.ri.YT'v beart disease was therefore
estimated to be 273 pr year (rangti 112-442).
!R 1La Ji ta! ta 2046
Introduction
Racent reviews bave conduded that ezpostur to passive
smaltiitg is harmful to health It~l. Tha effects of pasaave
smcAing on health have been reparted'to include acute effecta&
sucb u*a^er++ariM of aathma and aagi.oa, as we11 as chronic
eftects such as the incraased'risk of upper and lower airways
infection in children and tba inczeaxd risk of fnns uncer in
adults Nl:
Tbe asaooatioc of lung c.ncer with pasive smoking appear
to satiafy epidemiolopcal tritarie of causality le.s1 To dat. 13
studiee have be® completed in siz countries. 10 of which have
reported a positive associatioo betwem lung cancr and
pasaive smoking /sl Three studies have failed to show an
aaaodation r7sl, but in each study the precision of the effect
eatimates was such that an increased risk could not be rubd
wt Publication bis, is, bias which occurs when papers with
^o^iificant results are eitber not submitted or aozepted for
publication. has been put forward' as an explanation for the
association between passive smoking and lung canccr Iiol:
However. this claim has been criticised and discredited iiil.
More recenUy, evidence has begun to accumulate which
implicates passive smoking in the development of ischaemic
heart disease I1t14G
Passive smoking is therefore a potentially important public
health problem in New Zealand. aad'it is desirable to assess
the magnitude of the problem. Taking the relative risk
estimates reported in epidemiologlcal studies and applying
them ta estimates of the proportion of the New Zealand
population exposed to passive smoking, we have made a
preliminary eetimate of the impact of pasaive smoking on the
health of nonsmokers..
We here report estimates of the numbers of deaths from lung
cancer and ischaemic beart disease attributable to prolonged
exposure to passive smokmg in New Zealand in 1985: The
evidence of excess deaths from other causes-ieu cancers of
sites other than the lLwgs. and chronic respiratory disease-
due to passive smoking is more tenuous 12G Death from these
causes has therefore not been considered hers.
StatJsUt:al methods
The proportioo of deaths lrom a particnilar di.easa attributablato a
speaSa exposure is Jmown aa the pcqulatioa attnbutabie ruk IaLo
rcferred to as tbe a.twlbpc frsctoni:
If p is the proportion of tbe genai papuLtioo exposed to the raak
factor lin this cara involuntary smolnno and RR u tbe relauve nsY
tbea
of dying of the disease in ezpowd'ventu cone>3xi..d iodividuals,
t;be population attributable risk is given by list
PAR - p(RR,- 1)
pRR-1D+1'
'Ilus measure has bean used in many pr.vious studis.. including
two studis wbicb estimated tbe propcrsno of deatds io New Zealand
atznbutabie to active smoking jiaj7t u..il as in a Can.diaa awd'y
wbuh setlmatsd the proportion of lung caarer deatha attributable to
pa=ve smoicns n
In tbe current sWdy, the relative riak ercimat.s from ov.rssaa
studies wers appliod to New 7.alYnd' data on paacvs smolan~
ezpo.ura and the drivad populatim attributabis risks wa. tbae
applied to Iuat cs^ew and iach.emic b.at diiresae deatfts ia 1965
among p.rseaa who had never smoked fisF The populauon
attributable nska and deaths attributable to puave smokung ww+
m'ud .eparauty for men and:woeyn. and forarporun at home
and'u worit
EstJmation of exposura to passive smokirty
Farimat/oa of ezpoeurs to passive smotfng at home:.
Estimatea of the prevalence of exposure of never smokers to
passive smoking at home were obtained from the Auckland
heart study (work in progresal: The study found that 12.7%
of' never smoking men and 16.1 % of never smoking women
aged 35-64 yeirs in Aucklaad in 1987-88 were exposed to
paasive smoking in tbeir homea. Thex figures an not limited
to ezposttn to spousal smoking, but include exposure to all

338 NEW ZEALJ.ND SfED1CAL JOURNAL II lULY 190%
other sourcas of passive smoking withia the household On
the other Sand theee figuree are likelN to undetesumau the
effects of iong term exposure to spousal smoking. stace we
have not waen account of never, smoiters who have been
previously exposed to passive smoking: but are currently
widowed': separated. divorced. or tivtng wtch ezsmoker3,
E.timatoos of exposure to paaaive smoking in the warkplJ.ac
The prevalence of exposure to passive smokmg in the
woricplac+ was also obtatned from the Auckland bears study.
Itl this study. 33.6% and 23.4% of never smoking matt and
.vomen. aged 35-64 years ia Auckland in 198788. wen exposed
to passvve smoking at worr A recant random teiephone survey
of the Wellington reglon reported that the proportion of
nonsmokers exposed to pan.uve smoking in the .oritplan may
be even higher. reaching up co 80°b,i19t However a ssgaificant
proportion af the respondents reported: that most of their
exposure occurred dutang tea and lunch breaks. Therefore we
adopted the more conservative prevalence esttmaus.
Estimation of r.Iatllre risks associated'with e:posurs
to passive smoking
FAcimatioa ot the relative risk of lung cancer doe to p..ai..
.moking at bome: The relative risk of dyusg of lung canars
in never smokers exposed to spousaPsmoking was obtaaned'
from the pooled resulta of 10 case control studies and two
prospective studies 1201. The relative risk of lung cancer
mortality in women who harl never smoked and who were
marrud'to ever smokersm weignted by the Mantd'Ha.ns,t.l
pmocedura was 1.3 (95% confidence intarvaLl 1.1-1.51 Iml
There have been few studies .:' lung cancer among men who
have never smoked We have i+sumed. as others have done
RIL that the relative rask of luag cancer ih never smoking men
asrrled to ever smoking women is the same as for nsv.r
smoking women marned to ever smoking men ITable 1).
Tebie 1.-EarUmats of rn/atiw -x ofdrthe from 14ne canCM.snd
i.c6semic heart df.aese due to a.sive .motina. I>a% confldenca
intervaJl
Dis.as. RelLtove rs from
exposure a home R.lative risk from
e==poswe at wot
Sfee w'omm Mea Woman
Luns cancer 1.3 1.3 2.2 2.2
I1.1LS1 ;1.11.51 (1.4-3.01 I1I4-3.01
Iscbrmu heart
di+ease
1.3
1.2
2.3
1.9
hl.l1_Q1 L11i.el (1sW.4/ (1.4_TSI'
Eatimatiun of tbe relative riai ol lo.as eascQ due to p.saive
smokzng in the workplace: Tb& elevated lung cancer risk from
passive smoking has beea well eeublish.d but few studiee
have specifically examined ruks from woricpiica ezpoeur+s.
Thus iasuad of uaing direct escimat.ea, the relative rutk for
lung cancer death from ezpoetue to passive smoking in the
workplace was estimat..d via an ezpoettre reaponse
relationship derived by Repan and Lowrey If.21y They
estimated that the degree of exposure to passive smokin.g at
home_ at work. and at both sa ces correspooded'to respective
daily inhalation of 0.45. 1.82 and 2.27 mg of the particulate
pdu. of ambient tobacco smoke (e~ Aornrding to this model~
espcxure to palave smoidag at woric should rvult in a hiatier
r>sic for lung cancer than erposure at homa Haaed an tke
relacive risk rumate of 1.3 for bome espo.urs (Table 11, the
relative risk of lung cancer in per.oos arpoeed to paasve
smoking in the workpllsee was estimated to be 1+
40:3 z 1.8?J0.48). yielding a r.tative risk ..amatr a[ 2.2 (raoge:
L4-3.011Tabl. 1). Thia estimate is ennaist:mt with the relative
risk of 3.3 196% a.+a8da-o iat..wa1 1:0-10.51 ftr twer amnitaes
exposed to passove amokcng at work reqertad by Kabas aad
Wyndar issL in one of the few studl.e that has di-t;*: ;-b-^
e=pwur+ at worti 4om arpo.ar* at bu- Ho+.vair. ws have
.doptrd tbe mc:e conacvacve aetimaru of 22 (Table 11.
Eitima dra of the e.i.tfve ri.k d Lcka®ie bret di....e d.etf
doe to prsed" safto(IC/sg as bcmc ?be snnmat.s for the tdattrf
r¢sk ot iscb+.micheat dSa.w d.ath m nev.r smnitss ezz+a..d
mp"ytvsalokFSg wr. oix~a.d Sr~ W.da pnoid anabais
of 5ve cohort studies and'two casm control studies lut The
poo/.d' rolauve rtsk for man exposed to spou»L amona.
+etght.d by the 'Wantal-H'senszal proc.dure. was 1-3 /CI:
1.11.61: and the eoereapoading eetiT-- fa women was l.2
ICI: 1.1,1.41 12st
Fitisnatioe of the relicve rcuh of iaeh.amirbeart dls.a.edrth
due to passive smokin= in the woraplaci: Then u at prwnt
scaat data Otl the relauve rtsk Of irh-TK heut disaaae drath
due to passive smoking in the workplaee. The study by
5vendsen et aI (13L based on daa from the MRFIT tnaL
reported that the ralattve risk of coronary heart disease death
in men exposed to coworkers smake compared with mea
whose coworiters did not smoke. was 2.6 Iln However. the
risk estimau wau lmpredae CI: 0:512.7: p-O:231. and m
addition. the MRFIT trsal'iavolved mea who were at high rvk
of coronary heart disease at entry.
Neverthdaes, a higher vdue for the relettve riak of iae aemie
beaet disease death from ezposure to passive smoking in tbe
workplace aompared to the home ia c++nso-taat with tne greats
prevalence and intensity of exposure obtaused ia tbe former
setting Is4 Using th. same assumptions as in our caltuLauon
of the r.lative rult of lung cancer frcm paasive smokoing tn thl
workplace, we eetimated that the relative risk of ixhaettue
4r:eart disease death from paanve smoking in the workplan
was 2.3 Irange: 1.4-3:41 for maa and 1.9 (rang.c 1.4-2.3) for
woman. respectively (Table 11j
Estimation of deaths du to passive smoking
Tbere aea a cottsid.rable number of uncertaintaes in the
estimation of deaths due to pveive smoking in New Zealand.
These redau to unrR*ties in the number of deaths in never
smokers, the prevalence of ezposure to passive smoking, and
the relative risks due to passive smoking. The main
uncertainty stems from the relative rtsk esumates.
Aceordingiy, to provide a range of plausible valuen for the
population attzibutable rvics- the 95% confidenci interval for
the relative risk estimatas (Table 1) have been usedL and the
other e.stimates have beea rsgtirded u fized Rangp have alao
been provided for the estimates of the numliar of deaths in
never smokere ITablse 25) in order to give an indication of
their prsdsioa but thetie rsngea have not bem ua.d~ia furtbt
caicuiationa.
Estimatiba of lung taatesr deaths attributable to passi.e
smoldag at homc In 1985 there were 1197 lung cancer deaths
in New Zealkad (lal-86fi in mm aa&331 in womm. It was
estimated from the cancer regutry dtta that 8% Of these
deaths oeeurred in never smolCess (z.l. Therefore 69 male lung
cancer deaths. and 28 famale lling cancer deatha occurred in
never smokeas (TabL 2).
Tabi.2-Esdrnetad numbeeof deetls hoen h+np onear erttib%rtaW..
ta o..we.rywun to spoad vnoke in..M~ 2riand in tSMS..bV sa
M.a Wom.a
Total m of lung cancer deachs B66 331
% of'p.opl. who h.d tw~ smoitd 8% 8%
No at lung canc.r d.aths in rltor
wbo Ead never smobad
69
28
PrWvajdace of ae~w sawkwo
arpo..d to syw..l +mdrms
127;
16.110
Ralaave nak of htnt c-aor fer
a~o~~n rn spnoaal amos
1.3
1.3 .
IC11 tl.l1.s1 (1.11.51
PAR apouasf smdoa 3.7% e.Et
(rsaae/ f 1.Sd:0 x I I t.67. S S I
No ol Am= oaoer d.erJu a
o.vw smok.n atatbutahie te
R~W --k+at
3.
1
/nasw/ 11!dl 162f
PA&-pepalaioa amsDasabi+ tzak
Tb. poWlaac:i .m'sbutibie naka were calealated to be 3.7%
(tiasc 1_3l.0%1 for mea aad 4.6% (raaQc 1.B-7.5'y) for
wam.n (Table 21. 'I3s numbrs ot ]ung ra M- deacha in 1983
atal.'batibie to paea.e amoitms at home were therefore
..amaud tn ha~n been 3(rangc 1~) for men and 1 IrusgC
0-M Eor wosns. Qv=S at cc ~ of 4 Itanget 1.4 1.

JULt' 1989 %E>t' ZEALA.NQ vtEDif.41 JOt'RNtL
Estimation of lus= tascer deaths attributabie to paseive
smoking in the workplace: Assuming a relatave rtsk of2:2: the
population attributable risk for lung cancer deaths due to
passive smoking in the workplace is 28.7% lrange: 11.&40.M
(or men. and 21.9% (rattgec 8.631.9°61 for women,lTable 31.
The number of lung cancer deaths in never smokers
attributable to pasatve smokutg in thi workplace is therefort:
estimated to have been 20 Irange: 8-28) for men. and 6(range:
271 for women. giving a total of 26 (range: 10-351 (Table 31.
The tocal annual number of lung cancer deaths attributable
to pusive smoking is thus estisaated to have been 30 (range:
1141). of which 87Qb is attributable to exposure in the
workplace.
Teb+e 3. - Estitnated nutnbet of deaths from lung cancer attributable
to passive {mokinp inthe work plica in New Zealand. iM.bv sas
Man Women
No of lung cancer deatles in never
smokers 69 26
Ptevalence of esposure to pasaive
smokang to never smokan who work 33.6% 23.4'>i
Relauve risk of lung cancer for
ezposut+ to passive smoking at work 2.2 2.2
iCl) 11.47.01 11.43.01
PAR. work exposure 26.746 21.9%
Iran=ef 111.840.2*.l e8:b34:9~1
No lung canoer deatha in never
smoken attribucable to passive
smoktns at work ' 20 6
traagel &261 12-71
PAR- population aCtrlbfitable rtak
Deaths from ii-ebaemic beart disease attributable to pasaive
smoking at bome: Data on the proportion of iachaemic bean
disease deaths occurring in never smokers in New Zealand
were not available. We estuaatad this proportion by applying
the relative risks of ischaemic bean disease death - obtained
from the cohort atudy by Doll and Peto Ips.2e1- for each
category of smoking (never smoked. ezsmoker, smoking
between 114. 1524. and over 25 cigarettes per dayl to the
proporuoss of New Zealanders aged over 25 years in each
cateaory: based on the 1981 cearus data Irli!, The proportions
of aever smokers among iacbaemic been deaths were then
calculated as the percentage of all iscbaetnic bean disease
deaths that would be ezpected to oavr. based on there relative
risks. It was thua estimatod~ that 32.3% and 42.0% of
ischaemic heart disease deaths otns in male and female never
smoken, respactively. T6ese Ctgures are in close agreement
,with unpublished data from a coronary bean disease register
in Auckland (Jackson R: work in progress).
The population attributab{e risks for ischymv buartdissase
deaths in persons ezposed to spousal smoke were estimated
to be 3:7% (range: 1.37.1961in men. and 3.1% (1.6-6.1961 in
women (Table Cl, The number of ischaemic bean: disease
deaths attributable to passive smoking in the home in
estimated to have been 51(rangs. 18-971',i=1 maa aad,401ransa:
21801 in women. a total of 91 deaths franie: 30-1771:
Tabh 4. - Eatlmeted number of Matrta from iaehaeenlt haert dlaeree
emibutabN to paaeve eapoaas to apouW arnokino In New 2"iand.
101011. by eea
Man tvomae
Total' no of daetlis from IHD 4234 3106
% of pera}'s who had oevNr Imoilad 32.3% 42:0%
No of W41e who had asver smoked
Ptevale]ra of ilpOfUrtr to spoYaal 13ia l306
smoke a1Son[ mafrled neMf amokar7 12.7% 14.1%
Ralative riak of IHD for a:poeu»
to spousaJamoka
1.31
1.2
ICII i1.11.61 11.T1.41
PAR. spouaal amolta 3.7% 3.1%
Iransel (1.b7aT.l Il.b 6:I7~1
No of I7dD slaaths in oever smokers
attributable to spousal smokias
Si
40
lrsaa-I 116-971 121601 ,
PAR - populatwn attnbuuble risk: IHD'- iscbaamic lrart disasf+
139
Deaths from iachsemic bean diseaae attributablk to passive
smoking in be workplace: Since the risk of tschaern,c heart
diseax from active smoking dimirwhes rapidly after cessation
of smoking. it was assumed that the risk of lachaemu heart
disease death from exposure to paasive smoking in the
workplace would similarly decline after withdrawal from the
workforce. Fiuthertaore, the estimates of workplace exposure
used in this study (Tables 3 and SI were based on data for
Aucklanders aged 35~'i4 years. Thus. conservative estiraates
of ischaemic heart disease deaths due to exposure to pasve
smoking in the workplace were denved, from the number, of
ischaertuc heart disease deaths which occurred among those
of workutg age, it. those aged under 65 years. In this age group
there were 1276 deaths in men and 366 in women in 1985 11en
(Table SI.
Tabb 6-Esomatad nun+ber of derW from iect+wrnic -wrt 640ew
attributable to paaaive amokinf intAe workplsca in N*w Zealand
in t=
`teo Women
Total number of isclurmic lieart
disease dr«aths in Ppp4 aged
<6S years 1276 366
'b of people who had never smoksd 32.3% 42.0%
Number of iscrsem.ic heart disease
deaths in never smokers ated
<65 years 412 164
Prevalbnu of ~ espoeure to,passive
smoking in never smoksn who work 33.6% 23 4%
Relateve rtsk ofuchaemsc Fieartdiseaae from exposure to,paaatve
smoking in the workplace 2.3 1.9
ICI)01.4.3;41I 11 .42:5v
PAR. worltplaca exposure 30.4% 1' 4%
iranae) (11.8-44.6%1 16.626.0".I
No of iachaeauc Mart disease deaths
in never, smokets attributable to
smoking in the workplace 125 27
lranseli 149-1841 r13-401
PAR - population attributsble risk
The population attributable riaks for deaths from ischaemic
heart disease due to puaive smoking in the workpliace.
assuming relative risks of 2.3 for maa and 1.9 for won>n. were
30.4% (rangr: 11.8-44.6961 in men and 17.4% (range: 8.6-26.0'S1!
in, women. These yielded estimates of, 125 (raage: 49-1841
iscbaemic heart disease deaths in men. and 27 (range: 13-40)
deaths in womea a total of 132 deatll.s (rangr 62-2241 fTabik 51:
Discussion
The esti:natad~total of 30 lung cancer deaths attributable to
passive smoking represents 2.5% of all lung cancer deaths in
1985: and 31.6% of lung cancer deaths in those who had never
smoked. These resulta are similkr to previous estimates for
USA lei and' Canada Isl Repace and Lowrey estimated that
paasive smoking was responsible for 5% of the totallannua]'
lung cancer deatha, and 30% of the lung cantw deaths in never
smokers in the USA la} Wigla and Collishaw estimated that
in Canada passive smoking .ca,s r*eponsible for 2.3% of the
total annual lung c,nca- daaths. and'S1qs of lun,g caaae daatlis
in never smokers Ia{.!
It is eetimated that 243 deaths from isckW*Y hsart disaase
ocivered in 1985 due to passive smolting.'ibis ewpeeeecta 3.3%
of all -xbaemic heart diaeaae daatha. and 9.1% of iscba..m;c
heart disease deaths in never smokess. The total number of
deaths in New Zalaland in 1f183 bom h.tn; riacst, and iV'bag%^ ^
heart di,ease due to passive smoking was estimated to have
been 273 (range: 112-44,21: of which 66.2'1[, was attributable
to exposure in the workplace (Tabli 6).
As we have stressed throughout, thars are a number of
uncer-int»s in theae calntlarions, and the totil of 273 deaths
per year from lung catscez and iacbumic heart diss,ase due to
passive smoking should be regarded as only a preliminary
estimate. Nevertheltys it doee indicate the Likely magnitude
of the mortality due to pasaive smoking in New ZeaJand. The
findiaga of this study will nead to be revi.wd as more acrurats
data particularly on the reletive risks of diseaaes due to
workplace ezposure to passive smoking, become available.

340
NEW gA/^ND stEDICAL JOURNAL
However then arr a number of reasons to suggest tLat the
Ctgures presented herr are underestuaates. Firsdy, we have
not considered'the numbers of'd'eaths attributable to passive
smoking in two groups of nonsmohen:111 never smokers who
arm not currently esposed to passive smoking at home land
in t:he case of ischaetnuc heart disea.srcaaes. at worki. buMho
have been exposed in the paut. and (21 etsmokers currently
exposed to passive smoking. Sscondly..ve have not considered
exposure to passive smoking in situations other than at bome
or at work.,nor the impact of passive exposure to pipe or cisar
smoking. Thirdly. we have not made adjustments to the
relative risks for possible rrusclassification of szposures., In
studies which have corrected for these biases waat the net
effect of the adjustment was to raiss the relative risk
estimates. Fourthly. we have not attempted to estimate the
numbers of deaths from cancers of sites other than the lungs.
Based on three cohort and two case control studies. Wells
estimated that the relative risk of cancers other than the lunss
in never smoking women exposed to passive smoking was 1.16
43% confidence limits: 1.06-1.27)fz34 Excess cancers were
observed for cancers of the breast. cervix. brain. paranasal
sinuses and endocrine gland>t 1231. Although thesa studies
have been criticised for their failure to control for risk factors
known to be associated with cancers of these sites /21i it is
nevertheless Ukely that at leaat some deaths from ths.e caoair
types are attributable to passive smoking. Finally. we.have
notattempted to estimats the numbera of pneumonia deaths
attributable to passive smoking in chiliihood nor the ioawassd
numbers of perinatal deaths associated wnth smoking dunng
pregnancy 14
Despitt the uncertainties in the estimates presented'lun.&
they nevertheless suggest that passive smoking is a malor
public health problem in New Zealand. Although a more
precise estimate of the number of deaths due to pusive
smoking must await further studies, there is a clear case for
taking action on current evidence. The protection of the bealth
of nonsmokers. particularly in the workplace and in enclosed
public places. must be given priority as an iasw of
environmental health protection. It is encouraging that the
necessary regulatory actions are beginniag to occur.
Achaowledsmeats: The author. wish to thank Professor Robirt.
Beaglehok. DnHutA Bonita. DrDsvmd Hay and Dr Murrsy Laua.e.a
for thev valuabte advlce and susyeswons on eolier drafts of this
rnanuscrspt: DrKawachi is supported by a Medio! Res.arsh Couadl
of hew Z.alaed truaung feiiowship. Dr JKksoo'ls supported by the
Nu+onal Hiart Fauadawn of Nev 7a1acd and tM Med+cal nMe.rcl+
CouoaJ of New Lalaad. t Health,
Car*ee'e~aM.«: Dr I Kswschi Departzoent of Commun+ 5ouch:
t't''.4Jlastoo ScLool of MetLaee. PO Box 7313. K'ieLJnit o
R,aference,a
1V-rY Mi.1J r f4.~~ a6-rd C...el t AYVfIr ~A -! Mwie 100W(
w ruu Cw.~.. tsw .. ~.` M ur
7L'S Srrre G.w~a t1. ~Y..r.eri~.f.urwuW7rKwf
w~s. ewwa Mryi.y Us OMMS hWt Mr/u s.r.'f> IMe
».rSItul` IYt. M., J IIN e le"
.
9 M tp DT C.W.... ~ E KrtbMU JMw Y D..... r Crr. ».. wy ea.r/ ~.
Y YtM/11.YryYrt1A1 CY N./ Ass J IM^ 134 4
K.pa. J L. LMnr A M A eurYYUn. Y.rr. M.Y~~f, y'y s..~ nyi 1rr
."t1.eE.rv.. l+ t 1sN: 11 . >12:
T Ck.. WC crbaus MJ:.F.r sc. w LL ar..~a ~at..e t. M.y K.Y tfr'f.-. a. J Ca Iser » U2.Ft
~ auRlml r. nd1. L Xr T w aL Tb w...f h..e c.rw r T.ar L. .1ltuW M.
Ca+.. P.4 L!.ry mr urr ..e rw~w~ ~w Yort verw Clr~.
IhY..aNa.rl I fM f I~ r C6.ohrW. J. AY.~ M Itd.erW~.f ~ww...by Y rr d Vys~s
../ W rmu6e-.1.e.4..r" stJ C. 11M 54 r7,loS
lo v=wn-ea.Jr r..wMysu.yr.'a..WIJJfY
JM »112.
11 w.WAJ ~~rwN~rm/y4ay~r.rrYSrW'tLaYn arWtlJ1W
xsa 11a~
I1 G.ri.d C§awctL..r ESrnw L a a Cf1.eY.1 sww...amC ~~=1rs~~r
Ir.n 4..r nrt.b/r,.f iwaaY.n A. J E..e../e/ Isu t,1, als017 S.rr K H. KtJir LM: f1. WOetr J K
Etl.ev M. e..a.., osawS u Ye
aW6yr ~ frv taYr...~ vYt' Aa J E'pMrtl IM7: 121 `rJr!'
1. Ma.ar KJ S.dlr Dr G..Yd 6 W: C1r C Hw 6tsv er..uty r .~
LYr au' - Aa J CrMd IM/ IZT slbZ7, su ' - AM 1~...e.d DC E-.-..-..r..r..dsoa ae.a oa.a orP :reo
16 K.yD0. SrtS AH. fWV DM M.n.Yq .unAtYOr Y r~aa~y u ~w L.La\Z M.~ Iey'. M /tr.
17. GnrAJ It.aasJA.L're~M Tlrew..feev.aY..a.yr~wZ.Nr! %Z
1it.1'J 12411 t01 570...
il .ue" MWeAS,.M-Gwua. Mw%.Yty...eba.pyAa 4YIMd Mayarv
.y...l MWti SYWt.e C-1n. 11/'
1! D"Ytawt a/C~ty MWt[ rwsNi~ treitYt.eM tnrar.w.~{Ye !Y
..v rWcal iWOwt Ae/R w.W'y1e WI4~ StMwn d..MwLaa..lw70 oYr WJ r~Jr prw.r.tyle rWrt ns J %.W C.rm Ln
SMf T9
M>r
27 R..r J L L..r.r A H Pwt4eLae tL MuK( u.en rrY M Y...uc f1.ew ...rw4
A. 0.. sw Dulrel. tstIiO..
32 K.a.r GCC w r.w . EL Lry .as a a...aak.. C..w I M. 13 1 t1.-t 1
27 »d1. AJ A...L-t .t .nJt rn.Yq rti. lf..Yi1 SwY. Ira.'..rq +reW
E.wsme 1.t~y1Ltl 1sY. I... LFYi. srrN'Mwit 9r,u.arp. Cwoa C.r C.Y IIM bt.a w np.rrrr.ee e.M"
IN1 Yd 1962 . M'W'uela VµiN Hwlq S-Lmm t-tn IfLS
23 Dall IL hv IL Ma%anty. t. nlar Y...bae: !D r+MS.Y.r..~r.. r Mai. ar,uJpan~ . or Yty J Il7l
LSkiJl34..
X DW R G..r. R H.hw S. hu R M.WeT.o nVSa Y e.me.e 22 rrs ...,.
m r.m.ra Bnus! ewwr. 8, Md.J lsso I s./ca
r Dsvt~t ds~ V.. Zr1wC ~ .f yqiWS~ rae.wllap IMl eW/wra..~.ntY .nea.4 M.uYr... D........e.a Sst.wio
Isu7J r.W .J %.re." K tTa0p.r ffiM~.. CrrsJl MS'. D- b..rhrr nir p.ri.
Y.eo aot. ~ v.e orew's. Mr J lfM. ifJ121'a1
Congenital long QT syndrome in adults
Ian G Crozibr MD.,FRACP. Cardlbloyist:,Annamarie Louqhnan SSc. Cardirc Technician: Lazil J Dow
6Sc,
Cardiac Technician: Cflv J 5 Low MS. Chil. Cardioiogt Reqi'atrar:, Hamid' Ikram MD. FRCP.
Cardioioyiet.
Dapartment of Cardioibqy. Princeea Margaret Moapital. Chrtistchurch
Abstract
A family with the Romaao-Ward syndrome is present.d 7]us
family showed typical' features of this syndrome wtth QT
prolongation. torsades de pointes ventricular tachyeardta
sudden death and an autosomal dominant inheritance pattarn
The index case presented with an ez>,cerbation of torsadar de
pointes ventrieuJar tachycardia from diuretic induced
hypokalaetnit and respond.d to diurstir withdrawal and b.u
blocker therapy.
!R MY,.f J ts! I! arl
Introduction
Abnormalities of ventricular repolarisation predispose the
heart to ventricular arrhythmias. typically pol'ymorphsc
ventricular tachycardia (torsades de pointes): Abnormd~
repolarisation~ is typically represented on the surface
electrocardiogram by QT interval prolongation. However T
or U wave abnormalities may also reflect abnormal!
repolarisatioiL Abnormal repolarisation is usually acquired
due to cardiac injury:,metai+r+lic derangem.nt or drugs. Rar.ly:
abnormal repolarisation is congenital and may occur either
sporadically or a,s an auto.omJ11 r.caaaive or doaunant
coodicion:
We present a family witII auto.omal doraiaaat QT
prolongation and torsad.r da point.* ventJitvlar tachycardia
The patient
The lndes case was a se ysar old fnaalb witli a life long history of
syncope whied .u usually pr.npiuted by exertion or emouonal
streu Thr.e months pricr to sdmusioo she waa commeneed ae
cyclopentlu=de0.S mg d'aily for byp.rtansioa Sino coazuaenom.et
ot cycloprnthluide sh. reported that the syocopal episodes became
morw frequent and prolotta.d' Durias oae episods abe wu observed'
by her husband to be pale and pulseleaa. Sbe had no other stsnabust
put h,scory, and was on eo otbr medicauons On admission le
hosplul sbe wu ansious but othr+sse well. Blood pressure v+s
140,80 mmHi and a.oers! ^lotioo eormaL' Reetsag rhythm see>
